(Q28341894)
Statements
Phase II trial of fenretinide [N-(4-hydroxyphenyl) retinamide] in myelodysplasia: possible retinoid-induced disease acceleration (English)
0 references
1989
0 references
13
0 references
4
0 references
339-43
0 references